Accelerated Transcranial Ultrasound Neuromodulation in Parkinson's Disease: A Pilot Study
Movement Disorders · 2023-12 · 38 (12) · 2209-2216
DOI: 10.1002/mds.29622 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 09.10.2023. Verfasst von Nardin Samuel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Western Hospital, Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Motor Cortex. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
Low‐intensity transcranial focused ultrasound (TUS) is a novel method for neuromodulation. We aimed to study the feasibility of stimulating the bilateral primary motor cortices (M1) with accelerated theta‐burst TUS (a‐tbTUS) on neurophysiologic and clinical outcomes in Parkinson's disease (PD).
Methods
Patients were randomly assigned to receive active or sham a‐tbTUS for the first visit and the alternate condition on the second visit, at least 10 days apart. a‐tbTUS was administered in three consecutive sonications at 30‐minute intervals. We used an accelerated protocol to produce an additive effect of stimulation. Patients were studied in the OFF‐medication state. Transcranial magnetic stimulation (TMS)‐elicited motor‐evoked potentials (MEPs) were used to assess motor cortical excitability before and after TUS. Clinical outcomes after a‐tbTUS administration were assessed using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS)‐III.
Results
A total of 20 visits were conducted in 10 PD patients. Compared to the baseline, TMS‐elicited MEP amplitudes significantly increased following active but not sham sonication ( P = 0.0057). MEP amplitudes were also higher following a‐tbTUS than sham sonication ( P = 0.0064). There were no statistically significant changes in MDS‐UPDRS‐III scores with active or sham a‐tbTUS. Conclusions a‐tbTUS increases motor cortex excitability and is a feasible non‐invasive neuromodulation strategy in PD. Future studies should determine optimal dosing parameters and the durability of neurophysiologic and clinical outcomes in PD patients. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Toronto Western Hospital, Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.
- Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
- Edmond J. Safra Program in Parkinson's Disease and The Morton & Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
- Queen's University School of Medicine, Kingston, Ontario, Canada.
ORCID-Profile: Nardin Samuel, Can Sarica, Ghazaleh Darmani
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Samuel, N., Ding, M. Y. R., Sarica, C., Darmani, G., Harmsen, I. E., Grippe, T., Chen, X., Yang, A., Nasrkhani, N., Zeng, K., Chen, R., & Lozano, A. M. (2023). Accelerated Transcranial Ultrasound Neuromodulation in Parkinson's Disease: A Pilot Study. Movement Disorders, 38(12), 2209-2216. https://doi.org/10.1002/mds.29622
Vancouver
Samuel N, Ding MYR, Sarica C, Darmani G, Harmsen IE, Grippe T, et al. Accelerated Transcranial Ultrasound Neuromodulation in Parkinson's Disease: A Pilot Study. Movement Disorders. 2023;38(12):2209-2216. doi:10.1002/mds.29622
BibTeX
@article{Samuel2023,
author = {Samuel, Nardin and Ding, Mandy Yi Rong and Sarica, Can and Darmani, Ghazaleh and Harmsen, Irene E and Grippe, Talyta and Chen, Xingyu and Yang, Andrew and Nasrkhani, Negar and Zeng, Ke and Chen, Robert and Lozano, Andres M},
title = {Accelerated Transcranial Ultrasound Neuromodulation in Parkinson's Disease: A Pilot Study},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {12},
pages = {2209--2216},
doi = {10.1002/mds.29622}
}
EUVIMED